SPTLC1 and amyotrophic lateral sclerosis: This observation in conjunction with an analogous mechanism of loss of ORMDL regulation in SPTLC1 associated ALS provides a structural explanation for loss of ORMDL inhibition of SPT as a common mechanism for neurodegeneration that clinically manifests as early-onset ALS.